Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.
CONCLUSION: These results showed that neoadjuvant LET with zoledronic acid could not achieve overall effect for local tumor response. However, patients with a low frequency of γδ T cells would benefit from the treatment including zoledronic acid. (UMIN 000008701).
PMID: 29310035 [PubMed - as supplied by publisher]
Source: Breast - Category: Cancer & Oncology Authors: Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka Y, Hamazaki Y, Minato N, Toi M Tags: Breast Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | History of Medicine | Neoadjuvant Therapy | Reclast | Study | Women | Zometa